Trials / Completed
CompletedNCT06021444
Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee
A Multi-center, Randomized, Double-blind, Active-controlled, Pivotal, Non-inferiority Clinical Study to Evaluate the Efficacy and Safety of 'DKM420' in Knee Osteoarthritis Patients.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Dongkook Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To prove the non-inferiority of DKM420 by evaluating the injecting efficacy and safety DKM 420 and control for patients who have osteoarthritis of Knee.
Detailed description
A multi-center, randomized, double-blind, active-controlled, pivotal, non-inferiority clinical study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DKM420 | A total of 3 doses will be applied at a dose of 2 mL over 3 weeks. |
| DEVICE | Conjuran | A total of 3 doses will be applied at a dose of 2 mL over 3 weeks. |
Timeline
- Start date
- 2020-12-30
- Primary completion
- 2023-06-01
- Completion
- 2023-07-18
- First posted
- 2023-09-01
- Last updated
- 2023-09-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06021444. Inclusion in this directory is not an endorsement.